Dendritic Cells in Subcutaneous and Epicardial Adipose Tissue of Subjects with Type 2 Diabetes, Obesity, and Coronary Artery Disease

Dendritic cells (DCs) are professional antigen-presenting cells contributing to regulation of lymphocyte immune response. DCs are divided into two subtypes: CD11c-positive conventional or myeloid (cDCs) and CD123-positive plasmacytoid (pDCs) DCs. The aim of the study was to assess DCs (HLA-DR+ linea...

Full description

Bibliographic Details
Main Authors: Miloš Mráz, Anna Cinkajzlová, Jana Kloučková, Zdeňka Lacinová, Helena Kratochvílová, Michal Lipš, Michal Pořízka, Petr Kopecký, Jaroslav Lindner, Tomáš Kotulák, Ivan Netuka, Martin Haluzík
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2019/5481725
id doaj-9e2bc5837f8f45f8942e875c0e28104d
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Miloš Mráz
Anna Cinkajzlová
Jana Kloučková
Zdeňka Lacinová
Helena Kratochvílová
Michal Lipš
Michal Pořízka
Petr Kopecký
Jaroslav Lindner
Tomáš Kotulák
Ivan Netuka
Martin Haluzík
spellingShingle Miloš Mráz
Anna Cinkajzlová
Jana Kloučková
Zdeňka Lacinová
Helena Kratochvílová
Michal Lipš
Michal Pořízka
Petr Kopecký
Jaroslav Lindner
Tomáš Kotulák
Ivan Netuka
Martin Haluzík
Dendritic Cells in Subcutaneous and Epicardial Adipose Tissue of Subjects with Type 2 Diabetes, Obesity, and Coronary Artery Disease
Mediators of Inflammation
author_facet Miloš Mráz
Anna Cinkajzlová
Jana Kloučková
Zdeňka Lacinová
Helena Kratochvílová
Michal Lipš
Michal Pořízka
Petr Kopecký
Jaroslav Lindner
Tomáš Kotulák
Ivan Netuka
Martin Haluzík
author_sort Miloš Mráz
title Dendritic Cells in Subcutaneous and Epicardial Adipose Tissue of Subjects with Type 2 Diabetes, Obesity, and Coronary Artery Disease
title_short Dendritic Cells in Subcutaneous and Epicardial Adipose Tissue of Subjects with Type 2 Diabetes, Obesity, and Coronary Artery Disease
title_full Dendritic Cells in Subcutaneous and Epicardial Adipose Tissue of Subjects with Type 2 Diabetes, Obesity, and Coronary Artery Disease
title_fullStr Dendritic Cells in Subcutaneous and Epicardial Adipose Tissue of Subjects with Type 2 Diabetes, Obesity, and Coronary Artery Disease
title_full_unstemmed Dendritic Cells in Subcutaneous and Epicardial Adipose Tissue of Subjects with Type 2 Diabetes, Obesity, and Coronary Artery Disease
title_sort dendritic cells in subcutaneous and epicardial adipose tissue of subjects with type 2 diabetes, obesity, and coronary artery disease
publisher Hindawi Limited
series Mediators of Inflammation
issn 0962-9351
1466-1861
publishDate 2019-01-01
description Dendritic cells (DCs) are professional antigen-presenting cells contributing to regulation of lymphocyte immune response. DCs are divided into two subtypes: CD11c-positive conventional or myeloid (cDCs) and CD123-positive plasmacytoid (pDCs) DCs. The aim of the study was to assess DCs (HLA-DR+ lineage-) and their subtypes by flow cytometry in peripheral blood and subcutaneous (SAT) and epicardial (EAT) adipose tissue in subjects with (T2DM, n=12) and without (non-T2DM, n=17) type 2 diabetes mellitus undergoing elective cardiac surgery. Subjects with T2DM had higher fasting glycemia (8.6±0.7 vs. 5.8±0.2 mmol/l, p<0.001) and glycated hemoglobin (52.0±3.4 vs. 36.9±1.0 mmol/mol, p<0.001) and tended to have more pronounced inflammation (hsCRP: 9.8±3.1 vs. 5.1±1.9 mg/ml, p=0.177) compared with subjects without T2DM. T2DM was associated with reduced total DCs in SAT (1.57±0.65 vs. 4.45±1.56% for T2DM vs. non-T2DM, p=0.041) with a similar, albeit insignificant, trend in EAT (0.996±0.33 vs. 2.46±0.78% for T2DM vs. non-T2DM, p=0.171). When analyzing DC subsets, no difference in cDCs was seen between any of the studied groups or adipose tissue pools. In contrast, pDCs were increased in both SAT (13.5±2.0 vs. 4.6±1.9% of DC cells, p=0.005) and EAT (29.1±8.7 vs. 8.4±2.4% of DC, p=0.045) of T2DM relative to non-T2DM subjects as well as in EAT of the T2DM group compared with corresponding SAT (29.1±8.7 vs. 13.5±2.0% of DC, p=0.020). Neither obesity nor coronary artery disease (CAD) significantly influenced the number of total, cDC, or pDC in SAT or EAT according to multiple regression analysis. In summary, T2DM decreased the amount of total dendritic cells in subcutaneous adipose tissue and increased plasmacytoid dendritic cells in subcutaneous and even more in epicardial adipose tissue. These findings suggest a potential role of pDCs in the development of T2DM-associated adipose tissue low-grade inflammation.
url http://dx.doi.org/10.1155/2019/5481725
work_keys_str_mv AT milosmraz dendriticcellsinsubcutaneousandepicardialadiposetissueofsubjectswithtype2diabetesobesityandcoronaryarterydisease
AT annacinkajzlova dendriticcellsinsubcutaneousandepicardialadiposetissueofsubjectswithtype2diabetesobesityandcoronaryarterydisease
AT janaklouckova dendriticcellsinsubcutaneousandepicardialadiposetissueofsubjectswithtype2diabetesobesityandcoronaryarterydisease
AT zdenkalacinova dendriticcellsinsubcutaneousandepicardialadiposetissueofsubjectswithtype2diabetesobesityandcoronaryarterydisease
AT helenakratochvilova dendriticcellsinsubcutaneousandepicardialadiposetissueofsubjectswithtype2diabetesobesityandcoronaryarterydisease
AT michallips dendriticcellsinsubcutaneousandepicardialadiposetissueofsubjectswithtype2diabetesobesityandcoronaryarterydisease
AT michalporizka dendriticcellsinsubcutaneousandepicardialadiposetissueofsubjectswithtype2diabetesobesityandcoronaryarterydisease
AT petrkopecky dendriticcellsinsubcutaneousandepicardialadiposetissueofsubjectswithtype2diabetesobesityandcoronaryarterydisease
AT jaroslavlindner dendriticcellsinsubcutaneousandepicardialadiposetissueofsubjectswithtype2diabetesobesityandcoronaryarterydisease
AT tomaskotulak dendriticcellsinsubcutaneousandepicardialadiposetissueofsubjectswithtype2diabetesobesityandcoronaryarterydisease
AT ivannetuka dendriticcellsinsubcutaneousandepicardialadiposetissueofsubjectswithtype2diabetesobesityandcoronaryarterydisease
AT martinhaluzik dendriticcellsinsubcutaneousandepicardialadiposetissueofsubjectswithtype2diabetesobesityandcoronaryarterydisease
_version_ 1725069207836557312
spelling doaj-9e2bc5837f8f45f8942e875c0e28104d2020-11-25T01:34:59ZengHindawi LimitedMediators of Inflammation0962-93511466-18612019-01-01201910.1155/2019/54817255481725Dendritic Cells in Subcutaneous and Epicardial Adipose Tissue of Subjects with Type 2 Diabetes, Obesity, and Coronary Artery DiseaseMiloš Mráz0Anna Cinkajzlová1Jana Kloučková2Zdeňka Lacinová3Helena Kratochvílová4Michal Lipš5Michal Pořízka6Petr Kopecký7Jaroslav Lindner8Tomáš Kotulák9Ivan Netuka10Martin Haluzík11Department of Diabetes, Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech RepublicDepartment of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech RepublicDepartment of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech RepublicDepartment of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech RepublicDepartment of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech RepublicDepartment of Anaesthesiology, Resuscitation and Intensive Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech RepublicDepartment of Anaesthesiology, Resuscitation and Intensive Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech RepublicDepartment of Anaesthesiology, Resuscitation and Intensive Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic2nd Department of Surgery-Department of Cardiovascular Surgery, Charles University and General University Hospital, Prague, Czech RepublicAnesthesiology Department, Cardiac Centre, Institute for Clinical and Experimental Medicine, Prague, Czech RepublicCardiovascular Surgery Department, Cardiac Centre, Institute for Clinical and Experimental Medicine, Prague, Czech RepublicDepartment of Diabetes, Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech RepublicDendritic cells (DCs) are professional antigen-presenting cells contributing to regulation of lymphocyte immune response. DCs are divided into two subtypes: CD11c-positive conventional or myeloid (cDCs) and CD123-positive plasmacytoid (pDCs) DCs. The aim of the study was to assess DCs (HLA-DR+ lineage-) and their subtypes by flow cytometry in peripheral blood and subcutaneous (SAT) and epicardial (EAT) adipose tissue in subjects with (T2DM, n=12) and without (non-T2DM, n=17) type 2 diabetes mellitus undergoing elective cardiac surgery. Subjects with T2DM had higher fasting glycemia (8.6±0.7 vs. 5.8±0.2 mmol/l, p<0.001) and glycated hemoglobin (52.0±3.4 vs. 36.9±1.0 mmol/mol, p<0.001) and tended to have more pronounced inflammation (hsCRP: 9.8±3.1 vs. 5.1±1.9 mg/ml, p=0.177) compared with subjects without T2DM. T2DM was associated with reduced total DCs in SAT (1.57±0.65 vs. 4.45±1.56% for T2DM vs. non-T2DM, p=0.041) with a similar, albeit insignificant, trend in EAT (0.996±0.33 vs. 2.46±0.78% for T2DM vs. non-T2DM, p=0.171). When analyzing DC subsets, no difference in cDCs was seen between any of the studied groups or adipose tissue pools. In contrast, pDCs were increased in both SAT (13.5±2.0 vs. 4.6±1.9% of DC cells, p=0.005) and EAT (29.1±8.7 vs. 8.4±2.4% of DC, p=0.045) of T2DM relative to non-T2DM subjects as well as in EAT of the T2DM group compared with corresponding SAT (29.1±8.7 vs. 13.5±2.0% of DC, p=0.020). Neither obesity nor coronary artery disease (CAD) significantly influenced the number of total, cDC, or pDC in SAT or EAT according to multiple regression analysis. In summary, T2DM decreased the amount of total dendritic cells in subcutaneous adipose tissue and increased plasmacytoid dendritic cells in subcutaneous and even more in epicardial adipose tissue. These findings suggest a potential role of pDCs in the development of T2DM-associated adipose tissue low-grade inflammation.http://dx.doi.org/10.1155/2019/5481725